From: MR-based radiomics predictive modelling of EGFR mutation and HER2 overexpression in metastatic brain adenocarcinoma: a two-centre study
Metrics
Training cohort
Testing cohort
T1-CE
T2-FLAIR
AUC
0.98
0.86
0.82
0.70
ACC
0.93
0.74
0.62
SPE
0.67
0.69
SEN
0.92
0.83
0.73
0.57